PHARMACOTHERAPY OF INTRA-FETAL PATHOLOGIES

Authors

  • L. I. Bondarenko Regional Medical Center for Family Health of the Dnipropetrovsk Regional Council,
  • A. M. Bondarenko Kryvyi Rih National University

DOI:

https://doi.org/10.11603/1681-2727.2022.3.13486

Keywords:

intrauterine infections of the fetus, pharmacotherapy of the fetus, amnion, mathematical models

Abstract

SUMMARY. The article considers the main problems of pharmacotherapy of intrauterine fetal pathologies. An active search for the solution has been carried out, making the problem truly scientific, not empirical, and most importantly, accessible to practical clinical medicine. Studies have shown that the most promising method of fetal pharmacotherapy is the injection of pharmacological agents into the amniotic fluid. Mathematical models have been created based on the direct delivery of the pharmacological agents to the fetus, taking into account its gestational age, weight, physiological characteristics and volume of amniotic fluid in a developing pregnancy, which allows us to calculate: the initial dose of a drug to be injected into the amniotic fluid, as well as the dynamics of fetal oral absorption of the drugs. A theoretical base has been developed that allows to make this method of fetal pharmacotherapy universal, enabling it to be put into practice and used in a wide range of fetal pathologies in clinical medicine. The most promising area of this method application nowadays is the therapy of intrauterine fetal infections.

Author Biographies

L. I. Bondarenko, Regional Medical Center for Family Health of the Dnipropetrovsk Regional Council,

medical intern in Obstetrics and Gynecology of Regional Family Health Medical Center, Dnipro

A. M. Bondarenko, Kryvyi Rih National University

MD, Head of the Department of Ecology of Kryvyi Rih National University, Ukraine; consulting infectious disease specialist of Kryvyi Rih City Clinical Hospital No. 2; consulting infectious disease specialist of  Kryvyi Rih City Health Center

References

Bondarenko, A. M., Kopcha, V. S. (2010). Modern diagnosis and etiotropic treatment of toxoplasmosis in pregnant women: Guidelines. Kyiv [in Ukrainian].

Kimberlin, D. F., Weller, S., Whitley, R. J., Andrews, W. W., Hauth, J. C., Lakeman, F., & Miller, G. (1998). Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. American Journal of Obstetrics and Gynecology, 179 (4), 846-851.

Leung, D. T., Henning, P. A., Wagner, E. C., Blasig, A., Wald, A., Sacks, S. L., ... & Money, D. M. (2009). Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy. Journal of obstetrics and Gynaecology Canada, 31 (12), 1137-1143.

Sagar, R., Almeida-Porada, G., Blakemore, K., Chan, J. K., Choolani, M., Götherström, C., ... & David, A. L. (2020). Fetal and maternal safety considerations for in utero therapy clinical trials: iFeTiS Consensus Statement. Molecular Therapy, 28 (11), 2316-2319.

Machado, C. M., Castro, J. M., Campos, R. A., & Oliveira, M. J. (2019). Graves’ disease complicated by fetal goitrous hypothyroidism treated with intra-amniotic administration of levothyroxine. BMJ Case Reports CP, 12 (8), e230457.

Afanasiev, Yu. I., Yurina, N. A., Kotovsky, E. F. (2012). Histology, embryology, cytology: textbook. Moscow: GEOTAR-Media [in Russian].

Sadler, T. V. (2001). Medical embryology according to Langman. Lviv: «Nautilus».

Ailamazyan, E. K., Kulakov, V. I., Radzinsky, V. E., Savelyeva, G. M. (2009). Obstetrics. National leadership. Moscow: GEOTAR-Media [in Russian].

Published

2023-01-26

How to Cite

Bondarenko, L. I., & Bondarenko, A. M. (2023). PHARMACOTHERAPY OF INTRA-FETAL PATHOLOGIES . Infectious Diseases – Infektsiyni Khvoroby, (3), 52–62. https://doi.org/10.11603/1681-2727.2022.3.13486

Issue

Section

Reviews and lectures